Pretreatment Photopenia on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scans Predicts Poor Prognosis in Nasopharyngeal Cancer Patients Undergoing Concurrent Chemoradiotherapy

Objectives To investigate the influence of pretreatment primary tumor or nodal photopenia (PP) on 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT), an indicator of tumor ischemia, on survival results of nasopharyngeal cancers (NPCs) treated with concurrent chemora...

Full description

Bibliographic Details
Main Authors: Erkan Topkan, Ugur Selek, Hüseyin Mertsoylu, Yurday Ozdemir, Ahmet Kucuk, Nese Torun, Ali Ayberk Besen
Format: Article
Language:English
Published: Korean Society of Otorhinolaryngology-Head and Neck Surgery 2020-11-01
Series:Clinical and Experimental Otorhinolaryngology
Subjects:
Online Access:http://www.e-ceo.org/upload/pdf/ceo-2019-01298.pdf
id doaj-fd16dd1650e54e939f5369d4133cc40c
record_format Article
spelling doaj-fd16dd1650e54e939f5369d4133cc40c2020-11-25T04:00:16ZengKorean Society of Otorhinolaryngology-Head and Neck SurgeryClinical and Experimental Otorhinolaryngology1976-87102005-07202020-11-0113440741410.21053/ceo.2019.01298682Pretreatment Photopenia on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scans Predicts Poor Prognosis in Nasopharyngeal Cancer Patients Undergoing Concurrent ChemoradiotherapyErkan Topkan0Ugur Selek1Hüseyin Mertsoylu2Yurday Ozdemir3Ahmet Kucuk4Nese Torun5Ali Ayberk Besen6 Department of Radiation Oncology, Baskent University Medical Faculty, Adana, Turkey Department of Radiation Oncology, Koc University School of Medicine, Istanbul, Turkey Department of Medical Oncology, Baskent University Medical Faculty, Adana, Turkey Department of Radiation Oncology, Baskent University Medical Faculty, Adana, Turkey Clinics of Radiation Oncology, Mersin City Hospital, Mersin, Turkey Department of Nuclear Medicine, Baskent University Medical Faculty, Adana, Turkey Department of Medical Oncology, Baskent University Medical Faculty, Adana, TurkeyObjectives To investigate the influence of pretreatment primary tumor or nodal photopenia (PP) on 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT), an indicator of tumor ischemia, on survival results of nasopharyngeal cancers (NPCs) treated with concurrent chemoradiotherapy (C-CRT). Methods The pre-C-CRT FDG PET-CT scans of 104 patients with NPC (cT1-4 N0-3 M0) were retrospectively examined to determine the presence of PP (PP+). Our primary endpoint was the influence of PP+ on overall survival (OS), while the progression-free survival (PFS) and locoregional PFS (LRPFS) constituted the secondary endpoints. Results The PP+ was detected in 29 (27.9%): nine (8.7%), seven (6.7%), and 13 (12.5%) in the primary tumor alone, primary tumor plus neck nodes, and neck nodes alone, respectively. Because the PP+ cases were small by count per location, all comparative analyses were performed according to overall PP+/ PP– status instead of per detected site. At a median follow-up of 67.8 months (range, 9 to 130 months), the median survival times were not reached (NR) for the entire population, while 5-year OS, LRPFS, and PFS rates were 73.3%, 68.2%, and 63.4%, respectively. Comparatively the PP+ patients exhibited significantly poorer median OS (49.8 months vs. NR, P<0.001), LRPFS (40.7 months vs. NR, P=0.001), and PFS (31.8 months vs. NR, P=0.002) durations than their PP– counterparts. Furthermore, the PP+ retained its independent prognostic significance in multivariate analysis (P<0.001). Conclusion Present results uncovered the pre-C-CRT PP as an independent predictor of poor prognosis for NPC patients, which underscore the requirement for the fortification of the local and systemic treatments in hypoxic NPCs.http://www.e-ceo.org/upload/pdf/ceo-2019-01298.pdfnasopharyngeal neoplasmsconcurrent chemoradiotherapyphotopeniafdg-pet-ctprognosis
collection DOAJ
language English
format Article
sources DOAJ
author Erkan Topkan
Ugur Selek
Hüseyin Mertsoylu
Yurday Ozdemir
Ahmet Kucuk
Nese Torun
Ali Ayberk Besen
spellingShingle Erkan Topkan
Ugur Selek
Hüseyin Mertsoylu
Yurday Ozdemir
Ahmet Kucuk
Nese Torun
Ali Ayberk Besen
Pretreatment Photopenia on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scans Predicts Poor Prognosis in Nasopharyngeal Cancer Patients Undergoing Concurrent Chemoradiotherapy
Clinical and Experimental Otorhinolaryngology
nasopharyngeal neoplasms
concurrent chemoradiotherapy
photopenia
fdg-pet-ct
prognosis
author_facet Erkan Topkan
Ugur Selek
Hüseyin Mertsoylu
Yurday Ozdemir
Ahmet Kucuk
Nese Torun
Ali Ayberk Besen
author_sort Erkan Topkan
title Pretreatment Photopenia on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scans Predicts Poor Prognosis in Nasopharyngeal Cancer Patients Undergoing Concurrent Chemoradiotherapy
title_short Pretreatment Photopenia on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scans Predicts Poor Prognosis in Nasopharyngeal Cancer Patients Undergoing Concurrent Chemoradiotherapy
title_full Pretreatment Photopenia on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scans Predicts Poor Prognosis in Nasopharyngeal Cancer Patients Undergoing Concurrent Chemoradiotherapy
title_fullStr Pretreatment Photopenia on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scans Predicts Poor Prognosis in Nasopharyngeal Cancer Patients Undergoing Concurrent Chemoradiotherapy
title_full_unstemmed Pretreatment Photopenia on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scans Predicts Poor Prognosis in Nasopharyngeal Cancer Patients Undergoing Concurrent Chemoradiotherapy
title_sort pretreatment photopenia on 18f-fluorodeoxyglucose positron emission tomography-computed tomography scans predicts poor prognosis in nasopharyngeal cancer patients undergoing concurrent chemoradiotherapy
publisher Korean Society of Otorhinolaryngology-Head and Neck Surgery
series Clinical and Experimental Otorhinolaryngology
issn 1976-8710
2005-0720
publishDate 2020-11-01
description Objectives To investigate the influence of pretreatment primary tumor or nodal photopenia (PP) on 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT), an indicator of tumor ischemia, on survival results of nasopharyngeal cancers (NPCs) treated with concurrent chemoradiotherapy (C-CRT). Methods The pre-C-CRT FDG PET-CT scans of 104 patients with NPC (cT1-4 N0-3 M0) were retrospectively examined to determine the presence of PP (PP+). Our primary endpoint was the influence of PP+ on overall survival (OS), while the progression-free survival (PFS) and locoregional PFS (LRPFS) constituted the secondary endpoints. Results The PP+ was detected in 29 (27.9%): nine (8.7%), seven (6.7%), and 13 (12.5%) in the primary tumor alone, primary tumor plus neck nodes, and neck nodes alone, respectively. Because the PP+ cases were small by count per location, all comparative analyses were performed according to overall PP+/ PP– status instead of per detected site. At a median follow-up of 67.8 months (range, 9 to 130 months), the median survival times were not reached (NR) for the entire population, while 5-year OS, LRPFS, and PFS rates were 73.3%, 68.2%, and 63.4%, respectively. Comparatively the PP+ patients exhibited significantly poorer median OS (49.8 months vs. NR, P<0.001), LRPFS (40.7 months vs. NR, P=0.001), and PFS (31.8 months vs. NR, P=0.002) durations than their PP– counterparts. Furthermore, the PP+ retained its independent prognostic significance in multivariate analysis (P<0.001). Conclusion Present results uncovered the pre-C-CRT PP as an independent predictor of poor prognosis for NPC patients, which underscore the requirement for the fortification of the local and systemic treatments in hypoxic NPCs.
topic nasopharyngeal neoplasms
concurrent chemoradiotherapy
photopenia
fdg-pet-ct
prognosis
url http://www.e-ceo.org/upload/pdf/ceo-2019-01298.pdf
work_keys_str_mv AT erkantopkan pretreatmentphotopeniaon18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyscanspredictspoorprognosisinnasopharyngealcancerpatientsundergoingconcurrentchemoradiotherapy
AT ugurselek pretreatmentphotopeniaon18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyscanspredictspoorprognosisinnasopharyngealcancerpatientsundergoingconcurrentchemoradiotherapy
AT huseyinmertsoylu pretreatmentphotopeniaon18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyscanspredictspoorprognosisinnasopharyngealcancerpatientsundergoingconcurrentchemoradiotherapy
AT yurdayozdemir pretreatmentphotopeniaon18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyscanspredictspoorprognosisinnasopharyngealcancerpatientsundergoingconcurrentchemoradiotherapy
AT ahmetkucuk pretreatmentphotopeniaon18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyscanspredictspoorprognosisinnasopharyngealcancerpatientsundergoingconcurrentchemoradiotherapy
AT nesetorun pretreatmentphotopeniaon18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyscanspredictspoorprognosisinnasopharyngealcancerpatientsundergoingconcurrentchemoradiotherapy
AT aliayberkbesen pretreatmentphotopeniaon18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyscanspredictspoorprognosisinnasopharyngealcancerpatientsundergoingconcurrentchemoradiotherapy
_version_ 1724451561206185984